| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |